VoICE Immunization Evidence

Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina

Authored by: Giglio, N.D., Cane, A.D., Micone, P., et al

Appears in:

Key Idea

PCV7 use in Argentina resulted in an estimated cost of US$5,599 per life year gained and the purchase of the 4 doses of vaccine for the entire cohort at a cost of US$26.5 dose would require an investment of US$73,823,806.

Published In

Giglio, N.D., Cane, A.D., Micone, P., et al 2010. Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina. Vaccine. 28:2302–2310.